In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Long-term support release due in September has grown to 17 features including ahead-of-time command-line ergonomics and ahead-of-time method profiling. Java Development Kit (JDK) 25, a planned ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry ...

DNA Ginkgo Bioworks Holdings, Inc.

Use your voice to transform laser light into dazzling patterns. By humming, singing, or talking into the Vocal Visualizer, you’ll be able to see sound as vibration (or pressure waves) and experience ...

We are excited to announce the public launch of the Communication on Progress (CoP) Data Visualization Tools. These Tools offer insights into the progress of UN Global Compact business participants in ...